Bone Marrow Stromal Cells Produce Long-Term Pain Relief in Rat Models of Persistent Pain
- 26 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 29 (8) , 1294-1303
Abstract
Chronic pain conditions are difficult to treat and are major health problems. Bone marrow stromal cells (BMSCs) have generated considerable interest as a candidate for cell-based therapy. BMSCs are readily accessible and are easy to isolate and expand ex vivo. Clinical studies show that direct injection of BMSCs does not produce unwanted side effects and is well tolerated and safe. Here, we show that a single systemic (intravenous) or local injection (into the lesion site) of rat primary BMSCs reversed pain hypersensitivity in rats after injury and that the effect lasted until the conclusion of the study at 22 weeks. The pain hypersensitivity was rekindled by naloxone hydrochloride, an opioid receptor antagonist that acts peripherally and centrally, when tested at 1–5 weeks after BMSC infusion. In contrast, naloxone methiodide, a peripherally acting opioid receptor antagonist, only rekindled hyperalgesia in the first 3 weeks of BMSC treatment. Focal downregulation of brainstem mu opioid receptors by RNA interference (RNAi) reversed the effect of BMSCs, when RNAi was introduced at 5- but not 1-week after BMSC transplantation. Thus, BMSCs produced long-term relief of pain and this effect involved activation of peripheral and central opioid receptors in distinct time domains. The findings prompt studies to elucidate the cellular mechanisms of the BMSC-induced pain relieving effect and translate these observations into clinical settings.Keywords
Funding Information
- NIH (DE11964, DE018573, NS060735, NS059028, DE019156)
- Grant-in-Aid for Scientific Research (22592039)
- Japanese Ministry of Education, Science and Culture
This publication has 59 references indexed in Scilit:
- Interactions between the immune and nervous systems in painNature Medicine, 2010
- Molecular Depletion of Descending Serotonin Unmasks Its Novel Facilitatory Role in the Development of Persistent PainJournal of Neuroscience, 2010
- Long Lasting Pain Hypersensitivity following Ligation of the Tendon of the Masseter Muscle in Rats: A Model of Myogenic Orofacial PainMolecular Pain, 2010
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative MedicineJournal of Dental Research, 2009
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosisGlia, 2009
- Transplantation of Bone Marrow–Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in RatsDiabetes, 2008
- Supraspinal Glial–Neuronal Interactions Contribute to Descending Pain FacilitationJournal of Neuroscience, 2008
- Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI studyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Intravenous Administration of Marrow Stromal Cells (MSCs) Increases the Expression of Growth Factors in Rat Brain after Traumatic Brain InjuryJournal of Neurotrauma, 2004